Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial

Blood Cancer Journal
A PardananiAlessandro M Vannucchi

Abstract

Previous data established that plitidepsin, a cyclic depsipeptide, exerted activity in a mouse model of myelofibrosis (MF). New preclinical experiments reported herein found that low nanomolar plitidepsin concentrations potently inhibited the proliferation of JAK2V617F-mutated cell lines and reduced colony formation by CD34+ cells of individuals with MF, at least in part through modulation of p27 levels. Cells of MF patients had significantly reduced p27 content, that were modestly increased upon plitidepsin exposure. On these premise, an exploratory phase II trial evaluated plitidepsin 5 mg/m(2) 3-h intravenous infusion administered on days 1 and 15 every 4 weeks (q4wk). Response rate (RR) according to the International Working Group for Myelofibrosis Research and Treatment consensus criteria was 9.1% (95% CI, 0.2-41.3%) in 11 evaluable patients during the first trial stage. The single responder achieved a red cell transfusion independence and stable disease was reported in nine additional patients (81.8%). Eight patients underwent a short-lasting improvement of splenomegaly. In conclusion, plitidepsin 5 mg/m(2) 3-h infusion q4wk was well tolerated but had a modest activity in patients with primary, post-polycythaemia vera or ...Continue Reading

References

Mar 1, 1989·Controlled Clinical Trials·R Simon
Aug 1, 2002·Blood·Alessandro Maria VannucchiAnna Rita Migliaccio
Jul 8, 2005·Cancer Chemotherapy and Pharmacology·Ann M StraightGary L Francis
Jul 15, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BiscardiA Grossi
Apr 14, 2007·Molecular Cancer Therapeutics·Victoria MoneoAmancio Carnero
Dec 7, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Christian PeschelRalf-Dieter Hofheinz
Dec 20, 2007·The Journal of Pharmacology and Experimental Therapeutics·María J Muñoz-AlonsoAlberto Muñoz
Aug 12, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tim EisenMary O'Brien
May 27, 2009·Current Opinion in Hematology·Giovanni Barosi, Vittorio Rosti
May 12, 2010·Journal of Cellular Physiology·Maria VerrucciAnna Rita Migliaccio
Jun 10, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·María Victoria MateosJesús San Miguel
Oct 6, 2010·Cancer·Meetu AgrawalAlfonso Quintas-Cardama
Sep 6, 2011·Current Opinion in Oncology·Francisco Cervantes, Arturo Pereira
Dec 16, 2011·Current Hematologic Malignancy Reports·Madappa N KundrandaRuben A Mesa
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Apr 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John Mascarenhas, Ronald Hoffman
May 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Albert DeisserothRichard Pazdur

❮ Previous
Next ❯

Citations

Aug 19, 2015·Current Hematologic Malignancy Reports·Giovanni Barosi
Sep 24, 2005·Mayo Clinic Proceedings·Ayalew Tefferi, Tiziano Barbui
Aug 17, 2018·Future Oncology·Michael LeischRichard Greil

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electrophoresis
PCR
biopsies
GTPase

Clinical Trials Mentioned

NCT01149681

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.